Oxipit is a Vilnius company making AI chest X-ray products, ChestEye and ChestLink, that help radiologists with reporting.
Founded in 2017 in Vilnius, Lithuania, Oxipit, UAB develops AI imaging products that help radiologists with chest X-ray reporting, including ChestEye, released in 2019, and ChestLink, launched in 2022. Its customers are hospitals and radiology clinics in Europe, North America and parts of Asia, paying recurring subscription fees. Darius Barušauskas and Gediminas Peksys founded the company, and Peksys is CEO. In March 2026 Sectra AB agreed to acquire Oxipit from Taiwania Capital, Practica Capital and Coinvest Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in